Table III.
Association of TNBC with clinicopathological characteristics.
A, Unadjusted measures of association of TNBC with high tumor grade, LVI, LN status and pCR. | |||
---|---|---|---|
| |||
Characteristics | OR | 95% CI | P-value |
High grade | 8.89 | 3.12–28.55 | <0.001a |
LVI | 0.43 | 0.06–0.73 | 0.006a |
LN status | 1.16 | 0.49–2.78 | 0.70 |
pCR | 2.77 | 0.48–15.72 | 0.15 |
| |||
B, Adjusted ORs from a multivariate logistic regression analysis with TNBC as the dependent variable. | |||
| |||
Characteristics | OR | 95% CI | P-value |
| |||
High grade | 6.30 | 2.15–18.41 | <0.001a |
LVI | 0.28 | 0.08–0.92 | 0.036a |
LN statusb | 1.53 | 0.49–4.76 | 0.46 |
pCR | 2.38 | 0.24–24.14 | 0.46 |
Denotes statistical significance (P<0.05).
Presence of axillary lymph node metastasis.
TNBC, triple-negative breast cancer; LVI, lymphovascular invasion; LN, lymph node; pCR, pathological complete response; OR, odds ratio; CI, confidence interval.